Statutory Instrument 1997 No. 1830
The Prescription Only Medicines (Human Use) Order 1997 - continued
SCHEDULE 1 - continued

back to previous page

 
  Exemptions from the restrictions on the sale and supply of prescription only medicines
Column 1 Column 2 Column 3 Column 4 Column 5
Substance Maximum strength Route of
administration,
use or
pharmaceutical
form
Treatment limitations Maximum quantity
Nabilone        
Nabumetone        
Nadolol        
Nafarelin Acetate        
Naftidrofuryl Oxalate        
Naftifine Hydrochloride        
Nalbuphine Hydrochloride        
Nalidixic Acid        
Nalorphine Hydrobromide        
Naloxone Hydrochloride        
Naltrexone Hydrochloride        
Naphazoline Hydrochloride (1) 0.05 per cent (1) Nasal sprays or nasal drops not containing liquid paraffin as a vehicle    
  (2) 0.015 per cent (2) Eye drops    
Naphazoline Nitrate 0.05 per cent Nasal sprays or nasal drops not containing liquid paraffin as a vehicle    
Naproxen        
Naproxen Sodium        
Natamycin        
Nedocromil Sodium        
Nefazodone Hydrochloride        
Nefopam Hydrochloride        
Neomycin        
Neomycin Oleate        
Neomycin Palmitate        
Neomycin Sulphate        
Neomycin Undecanoate        
Neostigmine Bromide        
Neostigmine Methylsulphate        
Netilmicin Sulphate        
Nicardipine Hydrochloride        
Nicergoline        
Nicotinic Acid   Any use, except for the treatment of hyperlipidaemia 600mg (MDD)  
Nicoumalone        
Nifedipine        
Nifenazone        
Nikethamide        
Nimodipine        
Niridazole        
Nitrendipine        
Nitrofurantoin        
Nitrofurazone        
Nizatidine   For the prevention of the symptoms of food-related heartburn 75mg (MD)  
      Maximum of 4 such doses in any period of 14 days  
    For use in adults and children not less than 16 years    
Nomifensine Maleate        
Noradrenaline        
Noradrenaline Acid Tartrate        
Norethisterone        
Norethisterone Acetate        
Norethisterone Enanthate        
Norethynodrel        
Norfloxacin        
Norgestimate        
Norgestrel        
Nortriptyline Hydrochloride        
Noscapine        
Noscapine Hydrochloride        
Novobiocin Calcium        
Novobiocin Sodium        
Nux Vomica Seed        
Nystatin        
Octacosactrin        
Octreotide        
Oestradiol        
Oestradiol Benzoate        
Oestradiol Cypionate        
Oestradiol Dipropionate        
Oestradiol Diundecanoate        
Oestradiol Enanthate        
Oestradiol Phenylpropionate        
Oestradiol Undecanoate        
Oestradiol Valerate        
Oestriol        
Oestriol Succinate        
Oestrogenic Substances Conjugated        
Oestrone        
Ofloxacin        
Olsalazine Sodium        
Omeprazole        
Ondansetron Hydrochloride        
Orciprenaline Sulphate        
Orphenadrine Citrate        
Orphenadrine Hydrochloride        
Ouabain        
Ovarian Gland Dried        
Oxamniquine        
Oxantel Embonate        
Oxaprozin        
Oxatomide        
Oxedrine Tartrate        
Oxethazaine     10mg (MD) Container or package containing not more than 400mg of Oxethazaine
      30mg (MDD)  
Oxitropium Bromide        
Oxolinic Acid        
Oxpentifylline        
Oxprenolol Hydrochloride        
Oxybuprocaine Hydrochloride   Non-ophthalmic use    
Oxybutynin Hydrochloride        
Oxypertine        
Oxypertine Hydrochloride        
Oxyphenbutazone        
Oxyphencyclimine Hydrochloride        
Oxyphenonium Bromide     5mg (MD)  
      15mg (MDD)  
Oxytetracycline        
Oxytetracycline Calcium        
Oxytetracycline Dihydrate        
Oxytetracycline Hydrochloride        
Oxytocin, natural        
Oxytocin, synthetic        
Pancreatin (1) 21,000 European Pharmacopoeia units of lipase per capsule (1) capsules    
  (2) 25,000 European Pharmacopoeia units of lipase per gram (2) powder    
Pancuronium Bromide        
Papaverine   (1) By inhaler    
    (2) Otherwise than by inhaler (2) 50mg (MD)  
      150mg (MDD)  
Papaverine Hydrochloride   (1) By inhaler    
    (2) Otherwise than by inhaler (2) Equivalent of 50mg of Papaverine (MD)  
      Equivalent of 150mg of Papaverine (MDD)  
Paraldehyde        
Paramethadione        
Paramethasone Acetate        
Parathyroid Gland        
Pargyline Hydrochloride        
Paroxetine Hydrochloride        
Pecilocin        
Penamecillin        
Penbutolol Sulphate        
Penicillamine        
Penicillamine Hydrochloride        
Pentamidine Isethionate        
Penthienate Bromide     5mg (MD)  
      15mg (MDD)  
Pentolinium Tartrate        
Perfluamine        
Pergolide Mesylate        
Perhexiline Maleate        
Pericyazine        
Perindopril        
Perindopril Erbumine        
Perphenazine        
Phenacetin 0.1 per cent      
Phenazone   External    
Phenazone Salicylate        
Phenbutrazate Hydrochloride        
Phenelzine Sulphate        
Phenethicillin Potassium        
Phenformin Hydrochloride        
Phenglutarimide Hydrochloride        
Phenindione        
Phenoxybenzamine Hydrochloride        
Phenoxymethylpenicillin        
Phenoxymethylpenicillin Calcium        
Phenoxymethylpenicillin Potassium        
Phenprocoumon        
Phensuximide        
Phentolamine Hydrochloride        
Phentolamine Mesylate        
Phenylbutazone        
Phenylbutazone Sodium        
Phenylpropanolamine Hydrochloride   Internal    
    (1) all preparations except prolonged release capsules, nasal sprays and nasal drops (1) 25mg (MD)  
      100mg (MDD)  
    (2) prolonged release capsules (2) 50mg (MD)  
      100mg (MDD)  
  (3) 2.0 per cent (3) nasal sprays and nasal drops    
Phenytoin        
Phenytoin Sodium        
Phthalylsulphathiazole        
Physostigmine        
Physostigmine Aminoxide Salicylate        
Physostigmine Salicylate        
Physostigmine Sulphate        
Picrotoxin        
Pilocarpine        
Pilocarpine Hydrochloride        
Pilocarpine Nitrate        

 
continue
previous section contents Other UK SIs |  Home |  National Assembly for Wales Statutory Instruments |  Scottish Statutory Instruments |  Statutory Rules of Northern Ireland |  Her Majesty's Stationery Office

We welcome your comments on this site
© Crown copyright 1997
Prepared 27 August 1997